Form 4: UiPath CEO Sells Shares Under 10b5-1 Plan

UiPath CEO Daniel Dines sold 122,734 shares of Class A Common Stock for an average price of $16.5743 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

• Daniel Dines, CEO and Chairman of UiPath, Inc., sold 122,734 shares of Class A Common Stock.
• The transaction occurred on October 9, 2025.
• The shares were sold at an average price of $16.5743, with prices ranging from $16.2100 to $16.9800.
• This sale was conducted under a pre-arranged Rule 10b5-1 trading plan, which allows insiders to sell shares at a predetermined time or price to avoid accusations of insider trading.
• Following the transaction, Dines directly owns 29,918,585 shares and indirectly owns 613,670 shares through Ice Vulcan Holding Limited and 240,000 shares through his spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it is an insider sale, the execution under a Rule 10b5-1 plan suggests it is a pre-planned financial management decision rather than a reaction to new company-specific information, thus not inherently positive or negative for the company's outlook.

Positives

• The sale was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled transaction rather than a discretionary sale based on new material non-public information, which can mitigate concerns about insider trading.

Negatives

• An insider sale by a key executive, even if pre-planned, can sometimes be perceived negatively by the market, potentially leading to questions about management's confidence in the company's near-term prospects.

Stakeholder Impact

• Shareholders: May observe the insider sale and consider its implications, though the 10b5-1 plan mitigates immediate concerns about management's confidence.

Key Dates

Recommendation

The sale by CEO Daniel Dines was executed under a pre-arranged 10b5-1 plan, which suggests it is part of a personal financial management strategy rather than a reaction to new material information. While insider selling can sometimes be viewed negatively, the pre-planned nature mitigates immediate concerns. Investors should monitor future insider activity and company performance, but this single transaction does not fundamentally alter the investment thesis for UiPath, Inc. at this time.

Keywords

UiPath, PATH, Daniel Dines, insider trading, stock sale, 10b5-1, CEO, common stock